Nath Bio-Genes (India) Limited

₹138.25As of Sun 8 Nov 2026, 12:00 UTC
NSE:NATHBIOGENMaterials
Country India
PE (Fwd) •••
TSR 10Y CAGR (1.40%)
Div yield 1.45%
ROE 6.29%
Agricultural Inputs
Beta (5Y) 0.84
PE TTM 6.014
TSR TTM (19.34%)
Mkt cap ₹2.627B
ROIC 6.62%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹159
15.28%
(43.08%)
Hold 12|2|2|3|4
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
1.39
1.47
1.41
1.35
(4.29%)
4.39%
5.46%
4.40%
Revenue₹M
259.0
255.2
263.9
259.0
7.73%
8.56%
7.44%
0.17%
Peers (US$27.93M)
Cap (US$)
PE
23.26M
48.68x
21.60M
15.76x
Capital
TTM
5Y
10Y
Leveragex
0.927
0.264
0.215
EBIT/Intx
1.921
0.334
0.361
Own earn%
(107.76)
(214.20)
(186.53)
Sh yield%
48.61
63.87
59.95
Owners
Insiders/Inst%
5.80
86.45
Short interest%
1.88
SBC / revenue%
2.75
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
15–19
$1 testx
−0.1
Incr. ROIC%
4